Corporate News Report – Dyne Therapeutics (DYN)
Dyne Therapeutics (NASDAQ: DYN) closed the trading session at 11:35 AM Central Europe on Friday, 23 October 2026, down 1.23 % compared with the previous 24‑hour period. The stock is currently trading at approximately USD 15.77 on major exchanges.
Market Metrics
- Shares outstanding: 186.7 million
- Market capitalization: USD 3.00 billion
- 24‑hour trading volume: USD 28.8 million
- 12‑month change: -6.24 % since the end of September 2026
- 200‑day simple moving average: USD 19.36
- 52‑week high: USD 27.30 (12 August 2026)
- 52‑week low: USD 14.00 (2 March 2026)
Peer Performance (24 hours)
| Ticker | Price Change | Current Price | Market Cap | P/E |
|---|---|---|---|---|
| BOOT | +3.16 % | USD 119.76 | USD 3.5 bn | 14.69 |
| EXPO | +5.41 % | USD 77.11 | USD 3.5 bn | 32.84 |
| LMND | –0.26 % | USD 45.41 | USD 3.5 bn | – |
| ACAD | +0.59 % | USD 20.31 | USD 3.5 bn | 9.13 |
| LQDA | 0 % | USD 39.69 | USD 3.5 bn | 28.04 |
Company Overview
Dyne Therapeutics, Inc. is a biotechnology firm headquartered in Waltham, United States. The company specializes in the development of muscle‑targeted therapies aimed at treating serious medical conditions. Dyne Therapeutics is listed on the Nasdaq stock exchange and operates within the healthcare sector. Its official website is www.dyne-tx.com .
